Teva Pharmaceutical Industries Aktie
WKN: 883035 / ISIN: US8816242098
|
18.04.2026 10:44:00
|
3 Catalysts That Could Send Teva Stock to $40 and Beyond
After a multi-year slump, Teva Pharmaceutical Industries Limited (NYSE: TEVA) is on a roll. Shares of the Israel-based drugmaker have soared more than 130% over the last 12 months. Could Teva's momentum continue? Wall Street thinks so.Twelve of the 15 analysts surveyed by S&P Global (NYSE: SPGI) in April rated the pharmaceutical stock as a "buy" or "strong buy." There are three specific catalysts that could send Teva stock to $40 -- and perhaps beyond.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
Aktien in diesem Artikel
| Teva Pharmaceutical Industries Ltd | 30,34 | 0,50% |
|
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 29,60 | 0,00% |
|